THE DANGERS OF THE COVID 19 VACCINE REPORT NIC and CDC Protocols ARE Causing More COVID Deaths then Covid Alone!!! Prepared by Dr. Bryan Ardis

49:37
 
Share
 

Manage episode 302767473 series 2964724
By Jack Cambell. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

THE DANGERS OF THE COVID 19 VACCINE REPORT NIC and CDC Protocols ARE Causing More COVID Deaths then Covid Alone!!! Prepared by Dr. Bryan Ardis TABLE OF CONTENTS If You Have COVID: Why You Should NOT go to a HOSPITAL ............................... 1 COVID and Proven Protocols, One Medical and One Natural! ................................ 1 Did you know that Medical Doctors errors are the 3rd leading cause of death in America, in and out of Hospitals? ..................................................................... 1 CDC website directs patients and doctors to NIH Website for protocol ................... 1 Do you know what the side effects of this NIH recommended? ............................. 2 Adverse effects: ............................................................................................ 2 Serious adverse effects: ................................................................................. 2 Check out the World Meter Website which is tracking all the COVID Cases numbers and deaths worldwide..................................................................................... 3 Why is the NIH and CDC telling Hospitals to use Remdesivir? ............................... 8 The Truth about Hydroxychloroquine and COVID 19............................................ 9 Dr Ardis’ thoughts on Dr. Richard Bartlett’s Protocol. ........................................ 10 THE COVID MIRACLE DRUG: IVERMECTIN FLCCC.NET....................................... 14 COVID 19 VACCINES ................................................ 14 Some Numbers Listed as: Reported and (Actual) Deaths. .................................. 17 Now why are we telling people to get COVID 19 Shots?..................................... 17 ADDITIONAL RESOURCES ........................................ 19 Page 1 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT If You Have COVID: Why You Should NOT go to a HOSPITAL, and what you should ASK for if you are admitted to a hospital and have tested Positive for COVID! How to Prevent and Protect You and Your Loved Ones from COVID and Proven Protocols, One Medical and One Natural! Did you know that Medical Doctors errors are the 3rd leading cause of death in America, in and out of Hospitals? Between 250k and 440k killed every year! -John Hopkins University Study Suggests Medical Errors are now the third leading cause of death in the USA Now for COVID CDC website directs patients and doctors to NIH Website for protocol for treating COVID Patients. Here is the link to the CDC website. Click under “Management” section see the link to NIH site. Scroll down to “clinical management and treatment” and also “severe disease”, click link directing you to NIH guidelines. NIH issues Protocol to Hospitals, on how to treat COVID patients. Please take a moment to read the Remdesivir protocol on NIH site. Remdesivir is an INVESTIGATIONAL DRUG, and is NOT FDA APPROVED FOR ANYTHING Page 2 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT Do you know what the side effects of this NIH recommended? This investigational drug, which is also confirmed to NOT be FDA approved for any medical condition. Read the Remdesivir Drug Overview Read the Remdesivir Side Effects Please read the 3 summaries under the warning section, 3 Chinese produced findings from clinical experiences in CHINA on COVID patients. Please read the 3rd paragraph under the WARNING BOX on this page quoted below… I quote: Cohort of 53 hospitalized patients in manufacturer's compassionate-use program: Adverse effects: 1. Increased hepatic enzymes (evidence of liver damage) 2. Diarrhea (body rejecting it), rash (body trying to sweat out drug or allergic reaction to Remdesivir) 3. Renal impairment (kidneys are shutting down) 4. Hypotension (fatally low blood pressure), reported in 60% of patients. Serious adverse effects: 1. Multiple organ dysfunction syndrome (“more than one” organ failure) 2. Septic shock (life threatening) 3. Acute kidney injury (kidneys fail, body retains water, lungs fill with fluid causing pulmonary edema (lungs filling with fluid) being misdiagnosed as pneumonia, patients drown to death) 4. Hypotension (fatal low blood pressure)) reported in 23% of patients in the study. Page 3 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT Drug discontinued: because of adverse effects in 8% of patients. (people who had too severe side effects to continue the drug trial with Remdesivir. Memorize this number, 8%, In this Chinese group 8% of COVID patients had such severe side effects to the drug, that the doctors STOPPPED the REMDESIVIR treatment to not make them sicker or kill them. Now check out this stat. As of June 20,2020, according to worldmeter.com, 7% of all treated patients in America are dying in hospitals. That number is awfully close to this 8% being poisoned by Remdesivir in the Cohort study quoted above, from drugs.com. Ironic, I think NOT. Check out the World Meter Website which is tracking all the COVID Cases numbers and deaths worldwide. Tell me what the % is, of people who lived through treatment and the % OF THOSE THAT DIED… WHAT PERCENTAGE IS DYING AS A RESULT OF TREATMENT. Look it up. Did you know that United States has more than half of all the represented deaths from COVID in the entire world…? Can you guess why… Our NIH and CDC recommended protocol is POISONING our citizens and if it continues so will the massacre. Read the side effects “AGAIN” from the experiences in CHINA with this investigational drug…. Remdesivir I quote: “Cohort of 53 hospitalized patients in manufacturer's compassionate-use program: Adverse effects (e.g., increased hepatic enzymes, diarrhea, rash, renal impairment, hypotension) reported in 60% of patients. Serious adverse effects (e.g., multiple organ dysfunction syndrome, septic shock, acute kidney injury, hypotension) reported in 23%. Page 4 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT Drug discontinued because of adverse effects in 8% of patients. “ To help educate all the readers of this presentation, I have copied definitions for each of the ADVERSE SIDE EFFECTS listed above, due to being treated by REMDESIVIR. Definitions: Sourced from various reputable medical sources. Multiple Organ Dysfunction Syndrome: “The multiple organ dysfunction syndrome. The most common cause of death for patients admitted to a contemporary intensive care unit (ICU) is a clinical condition that owes its existence to the development of the ICU.” -John C Marshall, M.D. Acute Kidney Injury: Mayo Clinic in 2018 stated “Acute kidney failure can be fatal and requires intensive treatment. However, acute kidney failure may be reversible. If you're otherwise in good health, (COVID death victims are NOT in Good health) you may recover normal or nearly normal kidney function. Jun 23, 2018” Septic Shock: Medical News Today reports that- “Septic shock is a severe and potentially fatal condition that occurs when sepsis leads to life-threatening low blood pressure. Knowing how to recognize and prevent septic shock is vital. Sep 24, 2018” Hypotension: Mayo Clinic States-“Low blood pressure might seem desirable, and for some people, it causes no problems. However, for many people, abnormally low blood pressure (hypotension) can cause dizziness and fainting. In severe cases, low blood pressure can be life-threatening. Apr 21, 2020” Page 5 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT ** Here are 4 serious adverse reactions to Remdesivir, each of the 4 serious adverse reactions to the Drug from the studies are potentially FATAL!** Report in Science Magazine April 2020 Two quotes from the Science Magazine article linked above should sound alarm: Multiple battlefields (paragraph). “The worldwide fears of ventilator shortages for failing lungs have received plenty of attention. Not so a scramble for another type of equipment: dialysis machines. “If these folks are not dying of lung failure, they’re dying of renal failure,” says neurologist Jennifer Frontera of New York University’s Langone Medical Center, which has treated thousands of COVID-19 patients. Her hospital is developing a dialysis protocol with different machines to support additional patients. The need for dialysis may be because the kidneys, abundantly endowed with ACE2 receptors, present another viral target. According to one preprint, 27% of 85 hospitalized patients in Wuhan had kidney failure. Another reported that 59% of nearly 200 hospitalized COVID-19 patients in China’s Hubei and Sichuan provinces had protein in their urine, and 44% had blood; both suggest kidney damage. Those with acute kidney injury (AKI), were more than five times as likely to die as COVID-19 patients without it, the same Chinese preprint reported.” Crazy right… IMPORTANT! 1. DID YOU READ THAT?!!!!!!! Reported by China…” Those with acute kidney injury (AKI), were more than five times as likely to die as COVID-19 patients without it ”! 2. Stay with me... Those with Acute Kidney Injury are 5 X more likely to DIE than COVID patients without Acute Kidney Injury! Page 6 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT 3. Remdesivir: CAUSES “ACUTE KIDNEY INJURY IN 23% of ALL patients, per the drug makers cohort study!!!! quoted again from drugs.com “Serious adverse effects (e.g., multiple organ dysfunction syndrome, septic shock, ACUTE KIDNEY INJURY, hypotension) reported in 23%;” Logical Conclusion: If the NIH and CDC are going to enforce Hospitals to use Remdesivir as the go to drug for COVID patients, (remember it isn’t even an FDA approved drug for anything). And Remdesivir Causes Acute Kidney Failure in COVID patients as reported in China’s Cohort study, and COVID patients who experience ACUTE KIDNEY INJURY COVID victims are 5X more likely to die than COVID infected patients alone… Would it be logical and I scream, WOULD IT NOT BE LOGICAL TO “NOT” GIVE COVID POSTIVE PATIENTS A DRUG THAT IS PROVEN TO CAUSE ACUTE KIDNEY INJURY?!…THE ONE SIDE EFFECT OR ORGAN INJURY THAT ENSURES THE LIKELIHOOD OF YOU DYING GOES UP BY 5 times!!! Anyone else see the madness in pumping millions of people with this NON-FDA APPROVED, ACUTE KIDNEY INJURY-ing AND DEATH CAUSING “INVESTIGATIONAL” DRUG, REMDESIVIR. It is MADNESS… Why would our government health agencies push this proven poison known as Remdesivir? Why… it doesn’t make any sense. Second quote from Science Magazines article cited above: “The intestines are not the end of the disease’s march through the body. “For example, up to one-third of hospitalized patients develop conjunctivitis— pink, watery eyes—although it’s not clear that the virus directly invades the eye. Other reports suggest liver damage: More than half of COVID-19 patients hospitalized in two Chinese centers had elevated levels of enzymes indicating injury to the liver or bile ducts. But several experts told Science that direct viral invasion isn’t likely the culprit. Page 7 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT They say other events in a failing body, like drugs or an immune system in overdrive, are more likely driving the liver damage.” IMPORTANT! 1. All along, the treated COVID patients in hospitals are not only experiencing Acute Kidney Injury, but also LIVER DAMAGE! 2. Remember the Serious Adverse Reactions to Remdesivir (the ONLY drug these hospitals are being told to treat COVID patients with!) I quote again... “Serious adverse effects (e.g., MULTIPLE ORGAN DYSFUNCTION, septic shock, ACUTE KIDNEY INJURY, hypotension) reported in 23%;” 3. Remember the definition of MULTIPLE ORGAN DYSFUNCTION SYNDROME (now we have liver and kidney injury being reported by hospitals) here is the definition from John C. Marshall…. “The multiple organ dysfunction syndrome. The most common cause of death for patients admitted to a contemporary intensive care unit (ICU) is a clinical condition that owes its existence to the development of the ICU.” 4. Hospital treatments including Remdesivir, are CAUSING Multiple Organ Dysfunction Syndrome in COVID patients, and Multiple Organ Dysfunction Syndrome is the “The most common cause of death for patients admitted to a contemporary intensive care unit (ICU)” Conclusion: NIH hospital protocols using Remdesivir is causing COVID patients to experience Acute Kidney Injury and Multiple Organ Dysfunction Syndrome which is Literally Killing COVID 19 Patients 5 times more often than those suffering with COVID alone! Stop the DEADLY NON-FDA-APPROVED PROTOCOL! (* this report was created in June 2020, as of 10/2020, FDA has been pressured and has approved Remdesivir, after 8 months of killing thousands of American citizens) Page 8 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT Why is the NIH and CDC telling Hospitals to use Remdesivir? Because of a study on Ebola in Africa, four years ago, in which the Remdesivir trial group was taken OFF Remdesivir halfway through the trial and put on different medications being used in the study, BECAUSE Remdesivir had the HIGHEST MORTALITY RATES (DEATH RATE) of ALL 4 trial drugs!!! Rear the study and see for yourself: A Randomized, Controlled Trial Of Ebola Virus Therapeutics Check out Figure 1-4 in the Mortality section. Remdesivir had a higher percentage of death than ALL the other 3 trial medications for the Ebola Virus, in first 28 days of treatment. Follow these Study Results with the summaries quoted on drugs.com of Remdesivir side effects and in my opinion, you have a protocol of death, if you treat any COVID patients with Remdesivir. Now on to the next PROBLEM, I have with the Hospital protocols for COVID. WHY ARE THEY PRESCRIBING MULTIPLE ANTIBIOTICS TO COVID PATIENTS IF ANTIBIOTICS ONLY KILL BACTERIA? EVERY HUMAN BEING KNOWS COVID IS AN INFECTION OF A VIRUS, AND EVERY DOCTOR AND HOSPITAL KNOWS THAT ANTIBIOTICS DON’T TREAT OR KILL ANY VIRUSES, THEY ONLY TREAT BACTERIA INFECTIONS! A few articles from the trusted WebMD website and statements from the CDC on use of antibiotics when you someone has a virus not a bacteria infection. Read this WebMD article titled: Why you SHOULD NOT be prescribed antibiotics when you have a viral infection. “Antibiotics only cure certain infections due to bacteria -- and if taken carelessly, you may get more serious health problems than you bargained for. With any illness, it is critical to address the underlying cause, whether it's bacterial or viral. Antibiotics will not kill…viruses.” Page 9 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT Why in the WORLD are we adding ANTIBIOTICS to try and TREAT COVID, a known disease caused by a VIRUS? So now we are killing people who have COVID, with drug that is NOT FDA Approved drug (Remdesivir) and putting unwarranted bacterial drugs, called antibiotics (that have their own side effects which some include Acute Kidney Injury as a side effect) into people with confirmed virus infections. Aren’t we smarter than that? Appears not. Even the CDC has said that giving Antibiotics to people with Viral Infections is Dangerous!” Check out this article in Medical News Today titled: Taking Antibiotics for Viral Infections Can Do More Harm Than Good, CDC. “According to the US Centers for Disease Control and Prevention, where children are concerned, antibiotics are the most common cause of emergency department visits for adverse drug events. Rest, fluids, and over-the-counter medication is the preferred option for treating a virus, says the CDC. Colds and many other infections of the upper respiratory tract, plus some ear infections, are not caused by bacteria, but by viruses. Antibiotics do not work against viruses, only bacteria, yet although CDC efforts have led to fewer children receiving unnecessary antibiotics in recent years, too many are too often being given antibiotics for colds and other viral infections.” The Truth about Hydroxychloroquine and COVID 19 The Real Research Proven Benefits of Hydroxychloroquine (HCQ) and the STUDIES of its use with COVID patients. This link will show you the 66 medical research studies as of 05/2021 of HCQ use with COVID patients. Over 50 show positive results and almost 30 of these recent and current studies are PEER REVIEWED. Study the results and proof for yourself here. C19 Study There is even more hope however… Page 10 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT Go with what is safe proven and use medications when warranted that are FDA approved and proven effective against ANY viruses! First if you are going to do any medical treatment whatsoever use FDA approved medications. I personally would recommend Dr Richard Bartlett MD’s, COVID PROTOCOL which he combines with Zinc supplementation and has experienced 100% COVID cure like ALL his patients in Odessa, TX You can watch Dr Bartlett’s Interview on YouTube explaining his protocol and success with COVID patients, type this title of the interview in YouTubes Search engine. Dr. Richard Bartlett | ACWT Interview 7.2.20 Here is his paper submitted to Ted Cruz and delivered to the White House last week. Dr. Richard Bartlett Paper to Ted Cruz Be sure to check out the links below in his paper that reference how zinc and other nutrients help fight viruses including COVID-19 Respiratory Therapeutics Week. (2020, May 11). Coronavirus - COVID-19; The LEAD COVID-19 trial: Low-risk, early aspirin, and vitamin d to reduce COVID-19 hospitalizations. Skalny, A., Rink, L., Ajsuvakova, O., Aschner, M., Gritsenko, V., Alekseenko, S., Svistunov, A., Petrakis, D., Spandidos, D., Aaseth, J., Tsatsakis, A., & Tinkov, A. (2020). Zinc and respiratory tract infections: Perspectives for COVID-19 (Review). International Journal of Molecular Medicine, 46(1). Kumar, A., Kubota, Y., Chernov, M., & Kasuya, H. (2020). Potential role of zinc supplementation in prophylaxis and treatment of COVID-19. Medical Hypotheses, 144, 109848. Dr Ardis’ thoughts on Dr. Richard Bartlett’s Protocol. 1. I believe his protocol is safe and he is using ONLY FDA approved medications. Page 11 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT 2. He is NOT using investigational drugs (Remdesivir) that is proving to kill hundreds of thousands of people in hospitals. 3. I do not agree with his use of Antibiotics at all, but he is suggesting it short term, which is better, and if you are concerned enough about your health that you want to follow a medical protocol and have COVID, I would say 100% of the time. Demand Richard Bartlett’s Protocol, print his paper and give it to your primary care doctor. DO NOT GO TO THE HOSPITAL! 4. In my opinion the zinc supplementation is killing the virus, not the steroid, steroids don’t kill infections, just as antibiotics don’t kill viruses. However, Zinc for decades has proven to kill viruses and stop viruses from replicating! Know your rights as a Patient or Patient Advocate in Hospitals, It can and will save your life or loved one’s life! DR ARDIS’S RECOMMENDATIONS FOR ALL THOSE WHO CHOOSE TO TAKE A MORE NATURAL APPROACH TO BOOSTING YOUR IMMUNE SYSTEM AND HANDLING ANY INFECTION INCLUDING COVID, WITHOUT MEDICATIONS! Vitamin C (ascorbic acid): (preventative 3,000 mg daily/ with COVID 10,000 mg daily) has been shown for decades to have antiviral and antibacterial benefits. It increases our White Blood Cell count (our natural antibodies), and it specifically increases INTERFERON levels, which is a chemical factor our body makes that fights viral infections specifically! At specific doses our immune system can effectively handle the removal of any virus. Page 12 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT Here is some evidence. J. SCOTT, “ON THE BIOCHEMICAL SIMILARITIES OF ASCORBIC ACID AND INTERFERON,” J THEOR BIOL 98 (1982): 235-8. C. HUNT ET AL., “THE CLINICAL EFFECTS OF VITAMIN C SUPPLEMENTATION IN ELDERLY HOSPITALIZED PATIENTS WITH ACUTE RESPIRATORY INFECTIONS,” INT J VIT NUTR RES 64 (1994):212-9. H. BAUR AND H. STAUB. “TREATMENT OF HEPATITIS WITH INFUSIONS OF ASCORBIC ACID: COMPARISON WITH OTHER THERAPIES,” JAMA 156 (1954):565. E. GINTER, “OPTIMUM INTAKE OF VITAMIN C FOR THE HUMAN ORGANISM,” NUTR HEALTH 1 (1982): 66-77. Zinc: (50mg daily/ with COVID 100mg Daily, I prefer zinc gluconate) inhibits the growth of many viruses! A deficiency of zinc in the body causes suppression of the immune system by reducing white blood cell count, reducing T cell count, lowers thymus hormones that keep immunity strong. The immune systems strength immediately improves upon supplementation. Here is some evidence. J.W. HADDEN, “THE TREATMENT OF ZINC DEFICIENCY IS AN IMMUNOTHERAPY,” INT J IMMUNOPHARMAC 17 (1995): 697-701. M. DARDENNE, J. PLEAU, B. NABARRA, ET AL., “CONTRIBUTION OF ZINC AND OTHER METALS TO THE BIOLOGICAL ACTIVITY OF THE SERUM THYMIC FACTOR,” PROC NATL ACAD SCI 79 (1982): 5370-3. E. KATZ AND E. MARGALITH, “INHIBITION OF VACCINIA VIRUS MATURATION BY ZINC CHLORIDE,” ANTIMICROBIAL AGENTS CHEMOTHERAPY 19 (1981): 213-7. M. GERSHWIN, R. BEACH, AND L. HURLEY, “TRACE METALS, AGING, AND IMMUNITY,” J AM GER SOC 31 (1983): 374- 8. *PLUS, RICHARD BARTLETT’S TWO CITED ZINC STUDIES ABOVE IN HIS PROTOCOL Selenium: (Preventative 200mcg daily/ with COVID 400mcg daily) deficiency has been shown to inhibit resistance to infection because of impaired white blood cell and thymus function! Low in selenium, you cannot and will not be able to prevent the acquiring of the COVID-19 virus and its onslaught of symptoms. Selenium supplemented stimulates increase in white blood cells and increases immediately thymus function, thus empowering your immunity! DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT Here is some evidence. L. KIREMIDJIAN; SCHUMACHER AND G. STOTSKY, “SELENIUM AND IMMUNE RESPONSES,” ENVIRONMENTAL RES 42 (1987): 277-303. M. ROY, “SUPPLEMENTATION WITH SELENIUM AND HUMAN IMMUNE CELL FUNCTIONS 1: EFFECT ON LYMPHOCYTE PROLIFERATION AND INTERLEUKIN 2 RECEPTOR EXPRESSIONS,” BIOL TRACE ELEM RES 41 (1994):103-14. ECHINACEA: (PREVENTATIVE 900MG DAILY, WITH COVID 1800MG DAILY) HERBAL CAPSULES PROVIDE THE MOST POWERFUL PREVENTATIVE AND ACTIVE IMMUNITY AGAINST ALL VIRUSES INCLUDING THE CORONA VIRUS. EVERY ASPECT OF OUR INTERNAL IMMUNE SYSTEMS ARE ENHANCED BY ECHINACEA! IT MUST BE UTILIZED NOW TO HELP PROTECT ALL OF US. R. BAUER AND H. WAGNER, “ECHINACEA SPECIES AS POTENTIAL IMMUNOSTIMULATORY DRUGS,” ECON MED PLANT RES 5 (1991): 253-321. M. ERHARD ET AL., “EFFECT OF ECHINACEA ACONITUM, LACHESIS, AND APIS EXTRACTSM AND THEIR COMBINATIONS ON PHAGOCYTOSIS OF HUMAN GRANULOCYTES,” PHYTOTHER RES 8 (1994): 14-7 Your fear should be greatly reduced I hope after doing through ALL this information I have provided. I wish all of you and your loved ones the healthiest of lives and the least amount of stress and worry imaginable. There are better alternative approaches to beat and have victory over COVID-19. We NO LONGER NEED TO BE CRIPPLED BY FEAR. I plead with all of you to learn as much as you can about the nutritional protocol, I listed above to support your own bodies defenses against ALL viruses forever into the future. Our Natural Killer cells in our bodies are 99.997 percent effective at clearing and Page 13 of 20 Page 14 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT handling and healing from the COVID 19 virus and all other viruses! Before ever considering vaccine please look at the links I provide in the next section. THE COVID MIRACLE DRUG: IVERMECTIN FLCCC.NET IVERMECTIN is the GREATEST PROVEN DRUG TO PREVENT AND BEAT COVID19! With over 30 studies in 18 countries just in 2020 alone. To learn more please go to FLCCC.NET, if you haven’t seen Dr. Pierre Kory’s testimony before the senate in Washington pleading for the NIH to look at all the research, I would recommend you watch it! Ivermectin has been proven to STOP 100% of transmission of Covid 19 in less than 48 hours! None of the Covid 19 vaccines even state on their fact sheets that they protect you from getting covid and they don’t stop transmission of Covid. I beg you to learn more about Ivermectin. If your MD won’t prescribe it to you, then search the FLCCC.net website, they have directories around the world and US of MD’s who will write you a prescription. Check it out! COVID 19 VACCINES What should you know about COVID 19 Vaccines? An October 22, 2020, FDA internal report including Serious Adverse Events expected from the coming COVID-19 vaccines. In this presentation on slide #16 the FDA listed 110 possible diseases and neurological conditions and deaths, listed as expected Side Effects. These are expected to be reported when COVID-19 Vaccines become available in December 2020. This FDA report was published in October two months before the Emergency Use Authorization was published by the FDA, which includes NONE of the Serious Listed Side Effects listed in their internal report in October. Why would they exclude these expected horrible side effects in December, that they knew were to be expected in the October report. Anyone have a problem with this? I do. Page 15 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT Look at Slide 16… 2. Fact Sheets on FDA website for each Vaccine being administered state the vaccine is NOT FDA approved to prevent COVID 19. This is stated in the first paragraph of the EUA Fact Sheet. Check them out here, also look at the list of side effects possible from the Fact Sheet, and ask yourself, why did the FDA exclude in these Fact Sheets supposedly to be shared with citizens getting the COVID 19 vaccines, why did they exclude the listed Disease and Death side effects found on slide 16 from the FDA report in October, why are they hiding this from the public, this is conspiring to hide info. 3. What Serious Adverse Events are being reported to the government directly caused by COVID 19 Vaccines. Thousands of deaths and Serious life-threatening injuries reports to vaers.hhs.gov. You can download the updated list daily. 4. Harvard in 2010 published a report that less than 1% of ALL injuries from ALL vaccines are reported to VAERS. There have already been over 2000 deaths contributed and reported due to the COVID 19 Vaccines. If that represented less than 1 % reported to VAERS, than that means there has been possibly over 200,000 deaths due to the COVID vaccine alone. That is if you trust Harvard’s data. 5. Everyone I recommend watching this interview with Dr. Lee Merritt MD, licensed 30- year spinal surgeon who discusses why she promotes the use of Smallpox Vaccines and why she does NOT recommend COVID 19 Vaccines, and her medical and scientific use of masks. Here is the link. COVID-19 VACCINE INJURIES - THE NUMBERS Dr. Bryan Ardis Updated 5/17/2021 VAERS Data 5/7/2021, Less than 1% is being reported. Per Harvard’s 2010 Published review of the Vaccine Adverse Events Reporting System of the Dept. of Health and Human Services. Included in this report is the Harvard 2010 published review of the Page 16 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT government vaccine injury reporting system, please reference this link to the Harvard Report. First 150 days of Vaccinating Americans. (Please reference slide 16 from FDA’s report in October 2020, link is in my Covid report), they knew ALL of these were going to happen before they started pushing the vaccines in December 2020. Per the October Report slide 16 has 4 blood clotting issues listed as side effects. J&J reports in the media that 6 rare blood clots were enough to pause the J&J vaccine use. Numbers of reported Blood Clot related injuries to VAERS for all Vaccines is 3,272 means more likely 327,200 have occurred. Reported so far Pfizer (1,218 blood clot reports), Moderna 1,034 blood clot reports, and J &J (1,000 blood clot reports) Blood clot disorders reported total per VAERS.HHS.GOV: 3,272 (per Harvard it would be more like 327,200 have happened. 3,272 would be only 1% of actual events) Why has the Moderna and Pfizer vaccine distribution remained un-paused? All readers should do a search into which of these other three vaccines, Anthony Fauci’s Organization (NIAID) owns portions of the patent on one of these vaccines and he personally receives royalties on. It is NOT the J&J vaccine by the way. Page 17 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT Some Numbers Listed as: Reported and (Actual) Deaths 7/16/2021. VAERS Data Reported Injuries: 7/16/2021 Blood Clot related injuries: 7,633 (763,300) GUILLAIN-BARRE: 429 (42,900) PREGNANT WOMEN INJURED and/or MISCARRIED 2,488 (248,800) BELL’S PALSY 2,428 (242,800) NOT EVEN ON THE LIST FROM OCT SLIDE 16 SERIOUS ADVERSE EVENTS: 17,190 (1,719,000 EVENTS, FROM THE FDA OCT REPORT SLIDE 16) ANAPHYLACTIC SHOCK: 117,379, (11,737,900) THIS IS OVER 11 MILLION PEOPLE, ONLY 2 MILLION DIED WORLDWIDE SUPPOSEDLY. DISGUSTING. THIS IS JUST THE AMERICAN REPORTS. TOTAL ADVERSE EVENTS REPORTED: 192,954 (19,295,400) ADVERSE EVENTS. Now why are we telling people to get COVID 19 Shots? 626,769 Americans supposedly died from COVID as of 7/26/2021. Check this out… Deaths reported from Covid 19 Vaccines: 11,405 equals 1,140,500 probable deaths from COVID 19 Vaccines (16% Died within 24 hours of shots; 24% died in less than 48 hours) 21% due to Heart Attacks and Strokes For up-to-date VAERS underreporting data, sign up at Children’s Health Defense. They provide weekly email updates. To access data on COVID injuries reported go to VAERS.HHS.GOV! To get the latest updates from The Dr. Ardis Show please click the links below to subscribe! Page 18 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT This page intentionally left blank Page 19 of 20 DR. BRYAN ARDIS - DANGERS OF THE COVID 19 VACCINE REPORT ADDITIONAL RESOURCES Grant Final Report Grant ID: R18 HS 017045 Electronic Support for Public Health–Vaccine Adverse Event Reporting System (ESP:VAERS) Inclusive dates: 12/01/07 - 09/30/10 Principal Investigator: Lazarus, Ross, MBBS, MPH, MMed, GDCompSci Team members: Michael Klompas, MD, MPH Performing Organization: Harvard Pilgrim Health Care, Inc. Project Officer: Steve Bernstein Submitted to: The Agency for Healthcare Research and Quality (AHRQ) U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov 2 Abstract Purpose: To develop and disseminate HIT evidence and evidence-based tools to improve healthcare decision making through the use of integrated data and knowledge management. Scope: To create a generalizable system to facilitate detection and clinician reporting of vaccine adverse events, in order to improve the safety of national vaccination programs. Methods: Electronic medical records available from all ambulatory care encounters in a large multi-specialty practice were used. Every patient receiving a vaccine was automatically identified, and for the next 30 days, their health care diagnostic codes, laboratory tests, and medication prescriptions were evaluated for values suggestive of an adverse event. Results: Restructuring at CDC and consequent delays in terms of decision making have made it challenging despite best efforts to move forward with discussions regarding the evaluation of ESP:VAERS performance in a randomized trial and comparison of ESP:VAERS performance to existing VAERS and Vaccine Safety Datalink data. However, Preliminary data were collected and analyzed and this initiative has been presented at a number of national symposia. Key Words: electronic health records, vaccinations, adverse event reporting The authors of this report are responsible for its content. Statements in the report should not be construed as endorsement by the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services of a particular drug, device, test, treatment, or other clinical service. 3 Final Report Purpose This research project was funded to improve the quality of vaccination programs by improving the quality of physician adverse vaccine event detection and reporting to the national Vaccine Adverse Event Reporting System (VAERS), via the following aims: Aim 1. Identify required data elements, and develop systems to monitor ambulatory care electronic medical records for adverse events following vaccine administration. Aim 2. Prepare, and securely submit clinician approved, electronic reports to the national Vaccine Adverse Event Reporting System (VAERS). Aim 3. Comprehensively evaluate ESP:VAERS performance in a randomized trial, and in comparison to existing VAERS and Vaccine Safety Datalink data. Aim 4. Distribute documentation and application software developed and refined in Aims 1 and 2 that are portable to other ambulatory care settings and to other EMR systems. Scope Public and professional confidence in vaccination depends on reliable postmarketing surveillance systems to ensure that rare and unexpected adverse effects are rapidly identified. The goal of this project is to improve the quality of vaccination programs by improving the quality of physician adverse vaccine event detection and reporting to the national Vaccine Adverse Event Reporting System (VAERS). This project is serving as an extension of the Electronic Support for Public Health (ESP) project, an automated system using electronic health record (EHR) data to detect and securely report cases of certain diseases to a local public health authority. ESP provides a ready-made platform for automatically converting clinical, laboratory, prescription, and demographic data from almost any EHR system into database tables on a completely independent server, physically located and secured by the same logical and physical security as the EHR data itself. The ESP:VAERS project developed criteria and algorithms to identify important adverse events related to vaccinations in ambulatory care EHR data, and made attempts at formatting and securely sending electronic VAERS reports directly to the Centers for Disease Control and Prevention (CDC). Patient data were available from Epic System’s Certification Commission for Health Information Technology-certified EpicCare system at all ambulatory care encounters within Atrius Health, a large multispecialty group practice with over 35 facilities. Every patient receiving a vaccine was automatically identified, and for the next 30 days, their health care diagnostic codes, laboratory tests, and medication prescriptions are evaluated for values 4 suggestive of an adverse vaccine event. When a possible adverse event was detected, it was recorded, and the appropriate clinician was to be notified electronically. Clinicians in-basket messaging was designed to provide a preview a pre-populated report with information from the EHR about the patient, including vaccine type, lot number, and possible adverse effect, to inform their clinical judgment regarding whether they wish to send a report to VAERS. Clinicians would then have the option of adding free-text comments to prepopulated VAERS reports or to document their decision not to send a report. The CDC’s Public Health Information Network Messaging System (PHIN-MS) software was installed within the facilities so that the approved reports could be securely transferred to VAERS as electronic messages in an interoperable health data exchange format using Health Level 7 (HL7). Methods The goal of Aim 1: Identify required data elements, and develop systems to monitor ambulatory care electronic medical records for adverse events following vaccine administration, and Aim 2: Prepare, and securely submit clinician approved, electronic reports to the national Vaccine Adverse Event Reporting System (VAERS), was to construct the below flow of data in order to support the first two Aims: Figure 1. Overview of the ESP:VAERS project Existing and functioning ESP components are shown on the left, and Aims 1 and 2 on the right. ESP:VAERS flags every vaccinated patient, and prospectively accumulate that patient’s diagnostic codes, laboratory tests, allergy lists, vital signs, and medication prescriptions. A main component of Aim 1 was to Develop AE criteria to assess these parameters for new or abnormal values that might be suggestive of an adverse effect. A reporting protocol & corresponding algorithms were developed to detect potential adverse event cases using diagnostic codes, and methods were tested to identify prescriptions or abnormal laboratory values that might be suggestive of an adverse effect. These algorithms were designed to seek both expected and unexpected adverse effects. 5 This reporting protocol was approved by both internal & external partners. We initially prepared a draft document describing the elements, algorithms, interval of interest after vaccination, and actions for broad classes of post-vaccination events, including those to be reported immediately without delay (such as acute anaphylactic reaction following vaccination), those never to be reported (such as routine check-ups following vaccination) and those to be reported at the discretion and with additional information from the attending physician through a feedback mechanism. The draft was then widely circulated as an initial / working draft for comment by relevant staff in the CDC and among our clinical colleagues at Atrius. In addition to review by the internal CDC Brighton Collaboration liaison, this protocol has also received review & comment via the CDC’s Clinical Immunization Safety Assessment (CISA) Network. The goal of Aim 2 was the Development of HL7 messages code for ESP:VAERS to ensure secure transmission to CDC via PHIN-MS The goal of Aim 3 was to Comprehensively evaluate ESP:VAERS performance in a randomized trial, and in comparison to existing VAERS and Vaccine Safety Datalink data. . The HL7 specification describing the elements for an electronic message to be submitted to Constella, the consultants engaged by CDC for this project was implemented. Synthetic and real test data was been generated and transmitted between Harvard and Constella. However, real data transmissions of non-physician approved reports to the CDC was unable to commence, as by the end of this project, the CDC had yet to respond to multiple requests to partner for this activity. We had initially planned to evaluate the system by comparing adverse event findings to those in the Vaccine Safety Datalink project—a collaborative effort between CDC’s Immunization Safety Office and eight large managed care organizations. Through a randomized trial, we would also test the hypothesis that the combination of secure, computer-assisted, clinicianapproved, adverse event detection, and automated electronic reporting will substantially increase the number, completeness, validity, and timeliness of physician-approved case reports to VAERS compared to the existing spontaneous reporting system; however, due to restructuring at CDC and consequent delays in terms of decision making, it became impossible to move forward with discussions regarding the evaluation of ESP:VAERS performance in a randomized trial, and compare ESP:VAERS performance to existing VAERS and Vaccine Safety Datalink data. Therefore, the components under this particular Aim were not achieved. Aim 4 Distribution of documentation and application software developed and refined in Aims 1 and 2 that are portable to other ambulatory care settings and to other EMR systems has been successfully completed. Functioning source code is available to share under an approved open source license. ESP:VAERS source code is available as part of the ESP source code distribution. It is licensed under the LGPL, an open source license compatible with commercial use. We have added the ESP:VAERS code, HL7 and other specifications and documentation to the existing ESP web documentation and distribution resource center http://esphealth.org, specifically, the Subversion repository available at: http://esphealth.org/trac/ESP/wiki/ESPVAERS. 6 Results Preliminary data were collected from June 2006 through October 2009 on 715,000 patients, and 1.4 million doses (of 45 different vaccines) were given to 376,452 individuals. Of these doses, 35,570 possible reactions (2.6 percent of vaccinations) were identified. This is an average of 890 possible events, an average of 1.3 events per clinician, per month. These data were presented at the 2009 AMIA conference. In addition, ESP:VAERS investigators participated on a panel to explore the perspective of clinicians, electronic health record (EHR) vendors, the pharmaceutical industry, and the FDA towards systems that use proactive, automated adverse event reporting. Adverse events from drugs and vaccines are common, but underreported. Although 25% of ambulatory patients experience an adverse drug event, less than 0.3% of all adverse drug events and 1-13% of serious events are reported to the Food and Drug Administration (FDA). Likewise, fewer than 1% of vaccine adverse events are reported. Low reporting rates preclude or slow the identification of “problem” drugs and vaccines that endanger public health. New surveillance methods for drug and vaccine adverse effects are needed. Barriers to reporting include a lack of clinician awareness, uncertainty about when and what to report, as well as the burdens of reporting: reporting is not part of clinicians’ usual workflow, takes time, and is duplicative. Proactive, spontaneous, automated adverse event reporting imbedded within EHRs and other information systems has the potential to speed the identification of problems with new drugs and more careful quantification of the risks of older drugs. Unfortunately, there was never an opportunity to perform system performance assessments because the necessary CDC contacts were no longer available and the CDC consultants responsible for receiving data were no longer responsive to our multiple requests to proceed with testing and evaluation. Inclusion of AHRQ Priority Populations The focus of our project was the Atrius Health (formerly HealthOne) provider & patient community. This community serves several AHRQ inclusion populations, specifically lowincome and minority populations in primarily urban settings. Atruis currently employs approximately 700 physicians to serve 500,000 patients at more than 18 office sites spread throughout the greater Metropolitan Boston area. The majority of Atruis physicians are primary care internal medicine physicians or pediatricians but the network also includes physicians from every major specialty. The entire adult and pediatric population served by Atruis was included in our adverse event surveillance system (ESP:VAERS). Atruis serves a full spectrum of patients that reflects the broad diversity of Eastern Massachusetts. A recent analysis suggests that the population served by Atruis is 56% female, 16.6% African American, 4% Hispanic. The prevalence of type 2 diabetes in the adult population is 5.7%. About a quarter of the Atruis population is under age 18. 7 List of Publications and Products ESP:VAERS [source code available as part of the ESP source code distribution]. Licensed under the GNU Lesser General Public License (LGPL), an open source license compatible with commercial use. Freely available under an approved open source license at: http://esphealth.org. Lazarus, R, Klompas M, Hou X, Campion FX, Dunn J, Platt R. Automated Electronic Detection & Reporting of Adverse Events Following Vaccination: ESP:VAERS. The CDC Vaccine Safety Datalink (VSD) Annual Meeting. Atlanta, GA; April, 2008. Lazarus R, Klompas M Automated vaccine adverse event detection and reporting from electronic medical records. CDC Public Health Informatics Network (PHIN) Conference August 27, 2008. Klompas M, Lazarus R ESP:VAERS Presented at the American Medical Informatics Association Annual Symposium; 2009 November 17th. Lazarus R, Klompas M, Kruskal B, Platt R Temporal patterns of fever following immunization in ambulatory care data identified by ESP:VAERS Presented at the American Medical Informatics Association Annual Symposium; 2009 November 14–18: San Francisco, CA. Linder J, Klompas M, Cass B, et al. Spontaneous Electronic Adverse Event Reporting: Perspectives from Clinicians, EHR Vendors, Biopharma, and the FDA. Presented at the American Medical Informatics Association Annual Symposium; 2009 November 14–18: San Francisco, CA.

Revised: 12/2020 1 FACT SHEET FOR RECIPIENTS AND CAREGIVERS EMERGENCY USE AUTHORIZATION (EUA) OF THE MODERNA COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) IN INDIVIDUALS 18 YEARS OF AGE AND OLDER You are being offered the Moderna COVID-19 Vaccine to prevent Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2. This Fact Sheet contains information to help you understand the risks and benefits of the Moderna COVID-19 Vaccine, which you may receive because there is currently a pandemic of COVID-19. The Moderna COVID-19 Vaccine is a vaccine and may prevent you from getting COVID-19. There is no U.S. Food and Drug Administration (FDA) approved vaccine to prevent COVID-19. Read this Fact Sheet for information about the Moderna COVID-19 Vaccine. Talk to the vaccination provider if you have questions. It is your choice to receive the Moderna COVID-19 Vaccine. The Moderna COVID-19 Vaccine is administered as a 2-dose series, 1 month apart, into the muscle. The Moderna COVID-19 Vaccine may not protect everyone. This Fact Sheet may have been updated. For the most recent Fact Sheet, please visit www.modernatx.com/covid19vaccine-eua. WHAT YOU NEED TO KNOW BEFORE YOU GET THIS VACCINE WHAT IS COVID-19? COVID-19 is caused by a coronavirus called SARS-CoV-2. This type of coronavirus has not been seen before. You can get COVID-19 through contact with another person who has the virus. It is predominantly a respiratory illness that can affect other organs. People with COVID19 have had a wide range of symptoms reported, ranging from mild symptoms to severe illness. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may include: fever or chills; cough; shortness of breath; fatigue; muscle or body aches; headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; diarrhea. WHAT IS THE MODERNA COVID-19 VACCINE? The Moderna COVID-19 Vaccine is an unapproved vaccine that may prevent COVID-19. There is no FDA-approved vaccine to prevent COVID-19. The FDA has authorized the emergency use of the Moderna COVID-19 Vaccine to prevent COVID-19 in individuals 18 years of age and older under an Emergency Use Authorization (EUA). For more information on EUA, see the “What is an Emergency Use Authorization (EUA)?” section at the end of this Fact Sheet. Revised: 12/2020 2 WHAT SHOULD YOU MENTION TO YOUR VACCINATION PROVIDER BEFORE YOU GET THE MODERNA COVID-19 VACCINE? Tell your vaccination provider about all of your medical conditions, including if you: • have any allergies • have a fever • have a bleeding disorder or are on a blood thinner • are immunocompromised or are on a medicine that affects your immune system • are pregnant or plan to become pregnant • are breastfeeding • have received another COVID-19 vaccine WHO SHOULD GET THE MODERNA COVID-19 VACCINE? FDA has authorized the emergency use of the Moderna COVID-19 Vaccine in individuals 18 years of age and older. WHO SHOULD NOT GET THE MODERNA COVID-19 VACCINE? You should not get the Moderna COVID-19 Vaccine if you: • had a severe allergic reaction after a previous dose of this vaccine • had a severe allergic reaction to any ingredient of this vaccine WHAT ARE THE INGREDIENTS IN THE MODERNA COVID-19 VACCINE? The Moderna COVID-19 Vaccine contains the following ingredients: messenger ribonucleic acid (mRNA), lipids (SM-102, polyethylene glycol [PEG] 2000 dimyristoyl glycerol [DMG], cholesterol, and 1,2-distearoyl-sn-glycero-3-phosphocholine [DSPC]), tromethamine, tromethamine hydrochloride, acetic acid, sodium acetate, and sucrose. HOW IS THE MODERNA COVID-19 VACCINE GIVEN? The Moderna COVID-19 Vaccine will be given to you as an injection into the muscle. The Moderna COVID-19 Vaccine vaccination series is 2 doses given 1 month apart. If you receive one dose of the Moderna COVID-19 Vaccine, you should receive a second dose of the same vaccine 1 month later to complete the vaccination series. HAS THE MODERNA COVID-19 VACCINE BEEN USED BEFORE? The Moderna COVID-19 Vaccine is an unapproved vaccine. In clinical trials, approximately 15,400 individuals 18 years of age and older have received at least 1 dose of the Moderna COVID-19 Vaccine. WHAT ARE THE BENEFITS OF THE MODERNA COVID-19 VACCINE? In an ongoing clinical trial, the Moderna COVID-19 Vaccine has been shown to prevent COVID-19 following 2 doses given 1 month apart. The duration of protection against COVID-19 is currently unknown. Revised: 12/2020 3 WHAT ARE THE RISKS OF THE MODERNA COVID-19 VACCINE? Side effects that have been reported with the Moderna COVID-19 Vaccine include: • Injection site reactions: pain, tenderness and swelling of the lymph nodes in the same arm of the injection, swelling (hardness), and redness • General side effects: fatigue, headache, muscle pain, joint pain, chills, nausea and vomiting, and fever There is a remote chance that the Moderna COVID-19 Vaccine could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to one hour after getting a dose of the Moderna COVID-19 Vaccine. For this reason, your vaccination provider may ask you to stay at the place where you received your vaccine for monitoring after vaccination. Signs of a severe allergic reaction can include: • Difficulty breathing • Swelling of your face and throat • A fast heartbeat • A bad rash all over your body • Dizziness and weakness These may not be all the possible side effects of the Moderna COVID-19 Vaccine. Serious and unexpected side effects may occur. The Moderna COVID-19 Vaccine is still being studied in clinical trials. WHAT SHOULD I DO ABOUT SIDE EFFECTS? If you experience a severe allergic reaction, call 9-1-1, or go to the nearest hospital. Call the vaccination provider or your healthcare provider if you have any side effects that bother you or do not go away. Report vaccine side effects to FDA/CDC Vaccine Adverse Event Reporting System (VAERS). The VAERS toll-free number is 1-800-822-7967 or report online to https://vaers.hhs.gov/reportevent.html. Please include “Moderna COVID-19 Vaccine EUA” in the first line of box #18 of the report form. In addition, you can report side effects to ModernaTX, Inc. at 1-866-MODERNA (1-866-663- 3762). You may also be given an option to enroll in v-safe. V-safe is a new voluntary smartphone-based tool that uses text messaging and web surveys to check in with people who have been vaccinated to identify potential side effects after COVID-19 vaccination. V-safe asks questions that help CDC monitor the safety of COVID-19 vaccines. V-safe also provides second-dose reminders if needed and live telephone follow-up by CDC if participants report a significant health impact following COVID-19 vaccination. For more information on how to sign up, visit: www.cdc.gov/vsafe. Revised: 12/2020 4 WHAT IF I DECIDE NOT TO GET THE MODERNA COVID-19 VACCINE? It is your choice to receive or not receive the Moderna COVID-19 Vaccine. Should you decide not to receive it, it will not change your standard medical care. ARE OTHER CHOICES AVAILABLE FOR PREVENTING COVID-19 BESIDES MODERNA COVID-19 VACCINE? Currently, there is no FDA-approved alternative vaccine available for prevention of COVID-19. Other vaccines to prevent COVID-19 may be available under Emergency Use Authorization. CAN I RECEIVE THE MODERNA COVID-19 VACCINE WITH OTHER VACCINES? There is no information on the use of the Moderna COVID-19 Vaccine with other vaccines. WHAT IF I AM PREGNANT OR BREASTFEEDING? If you are pregnant or breastfeeding, discuss your options with your healthcare provider. WILL THE MODERNA COVID-19 VACCINE GIVE ME COVID-19? No. The Moderna COVID-19 Vaccine does not contain SARS-CoV-2 and cannot give you COVID-19. KEEP YOUR VACCINATION CARD When you receive your first dose, you will get a vaccination card to show you when to return for your second dose of the Moderna COVID-19 Vaccine. Remember to bring your card when you return. ADDITIONAL INFORMATION If you have questions, visit the website or call the telephone number provided below. To access the most recent Fact Sheets, please scan the QR code provided below. Moderna COVID-19 Vaccine website Telephone number www.modernatx.com/covid19vaccine-eua 1-866-MODERNA (1-866-663-3762) HOW CAN I LEARN MORE? • Ask the vaccination provider • Visit CDC at https://www.cdc.gov/coronavirus/2019-ncov/index.html • Visit FDA at https://www.fda.gov/emergency-preparedness-and-response/mcm-legalregulatory-and-policy-framework/emergency-use-authorization • Contact your state or local public health department Revised: 12/2020 5 WHERE WILL MY VACCINATION INFORMATION BE RECORDED? The vaccination provider may include your vaccination information in your state/local jurisdiction’s Immunization Information System (IIS) or other designated system. This will ensure that you receive the same vaccine when you return for the second dose. For more information about IISs, visit: https://www.cdc.gov/vaccines/programs/iis/about.html. WHAT IS THE COUNTERMEASURES INJURY COMPENSATION PROGRAM? The Countermeasures Injury Compensation Program (CICP) is a federal program that may help pay for costs of medical care and other specific expenses of certain people who have been seriously injured by certain medicines or vaccines, including this vaccine. Generally, a claim must be submitted to the CICP within one (1) year from the date of receiving the vaccine. To learn more about this program, visit www.hrsa.gov/cicp/ or call 1-855-266-2427. WHAT IS AN EMERGENCY USE AUTHORIZATION (EUA)? The United States FDA has made the Moderna COVID-19 Vaccine available under an emergency access mechanism called an EUA. The EUA is supported by a Secretary of Health and Human Services (HHS) declaration that circumstances exist to justify the emergency use of drugs and biological products during the COVID-19 pandemic. The Moderna COVID-19 Vaccine has not undergone the same type of review as an FDAapproved or cleared product. FDA may issue an EUA when certain criteria are met, which includes that there are no adequate, approved, and available alternatives. In addition, the FDA decision is based on the totality of the scientific evidence available showing that the product may be effective to prevent COVID-19 during the COVID-19 pandemic and that the known and potential benefits of the product outweigh the known and potential risks of the product. All of these criteria must be met to allow for the product to be used during the COVID-19 pandemic. The EUA for the Moderna COVID-19 Vaccine is in effect for the duration of the COVID-19 EUA declaration justifying emergency use of these products, unless terminated or revoked (after which the products may no longer be used). ©2020 ModernaTX, Inc. All rights reserved. Patent(s): www.modernatx.com/patents Revised: 12/2020 1 Revised: December 2020 FACT SHEET FOR RECIPIENTS AND CAREGIVERS EMERGENCY USE AUTHORIZATION (EUA) OF THE PFIZER-BIONTECH COVID-19 VACCINE TO PREVENT CORONAVIRUS DISEASE 2019 (COVID-19) IN INDIVIDUALS 16 YEARS OF AGE AND OLDER You are being offered the Pfizer-BioNTech COVID-19 Vaccine to prevent Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV-2. This Fact Sheet contains information to help you understand the risks and benefits of the Pfizer-BioNTech COVID-19 Vaccine, which you may receive because there is currently a pandemic of COVID-19. The Pfizer-BioNTech COVID-19 Vaccine is a vaccine and may prevent you from getting COVID-19. There is no U.S. Food and Drug Administration (FDA) approved vaccine to prevent COVID-19. Read this Fact Sheet for information about the Pfizer-BioNTech COVID-19 Vaccine. Talk to the vaccination provider if you have questions. It is your choice to receive the Pfizer-BioNTech COVID-19 Vaccine. The Pfizer-BioNTech COVID-19 Vaccine is administered as a 2-dose series, 3 weeks apart, into the muscle. The Pfizer-BioNTech COVID-19 Vaccine may not protect everyone. This Fact Sheet may have been updated. For the most recent Fact Sheet, please see www.cvdvaccine.com. WHAT YOU NEED TO KNOW BEFORE YOU GET THIS VACCINE WHAT IS COVID-19? COVID-19 disease is caused by a coronavirus called SARS-CoV-2. This type of coronavirus has not been seen before. You can get COVID-19 through contact with another person who has the virus. It is predominantly a respiratory illness that can affect other organs. People with COVID-19 have had a wide range of symptoms reported, ranging from mild symptoms to severe illness. Symptoms may appear 2 to 14 days after exposure to the virus. Symptoms may include: fever or chills; cough; shortness of breath; fatigue; muscle or body aches; headache; new loss of taste or smell; sore throat; congestion or runny nose; nausea or vomiting; diarrhea. WHAT IS THE PFIZER-BIONTECH COVID-19 VACCINE? The Pfizer-BioNTech COVID-19 Vaccine is an unapproved vaccine that may prevent COVID-19. There is no FDA-approved vaccine to prevent COVID-19. 2 Revised: December 2020 The FDA has authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine to prevent COVID-19 in individuals 16 years of age and older under an Emergency Use Authorization (EUA). For more information on EUA, see the “What is an Emergency Use Authorization (EUA)?” section at the end of this Fact Sheet. WHAT SHOULD YOU MENTION TO YOUR VACCINATION PROVIDER BEFORE YOU GET THE PFIZER-BIONTECH COVID-19 VACCINE? Tell the vaccination provider about all of your medical conditions, including if you: • have any allergies • have a fever • have a bleeding disorder or are on a blood thinner • are immunocompromised or are on a medicine that affects your immune system • are pregnant or plan to become pregnant • are breastfeeding • have received another COVID-19 vaccine WHO SHOULD GET THE PFIZER-BIONTECH COVID-19 VACCINE? FDA has authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine in individuals 16 years of age and older. WHO SHOULD NOT GET THE PFIZER-BIONTECH COVID-19 VACCINE? You should not get the Pfizer-BioNTech COVID-19 Vaccine if you: • had a severe allergic reaction after a previous dose of this vaccine • had a severe allergic reaction to any ingredient of this vaccine. WHAT ARE THE INGREDIENTS IN THE PFIZER-BIONTECH COVID-19 VACCINE? The Pfizer-BioNTech COVID-19 Vaccine includes the following ingredients: mRNA, lipids ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 2 [(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 1,2-Distearoyl-sn-glycero-3- phosphocholine, and cholesterol), potassium chloride, monobasic potassium phosphate, sodium chloride, dibasic sodium phosphate dihydrate, and sucrose. HOW IS THE PFIZER-BIONTECH COVID-19 VACCINE GIVEN? The Pfizer-BioNTech COVID-19 Vaccine will be given to you as an injection into the muscle. The Pfizer-BioNTech COVID-19 Vaccine vaccination series is 2 doses given 3 weeks apart. If you receive one dose of the Pfizer-BioNTech COVID-19 Vaccine, you should receive a second dose of this same vaccine 3 weeks later to complete the vaccination series. 3 Revised: December 2020 HAS THE PFIZER-BIONTECH COVID-19 VACCINE BEEN USED BEFORE? The Pfizer-BioNTech COVID-19 Vaccine is an unapproved vaccine. In clinical trials, approximately 20,000 individuals 16 years of age and older have received at least 1 dose of the Pfizer-BioNTech COVID-19 Vaccine. WHAT ARE THE BENEFITS OF THE PFIZER-BIONTECH COVID-19 VACCINE? In an ongoing clinical trial, the Pfizer-BioNTech COVID-19 Vaccine has been shown to prevent COVID-19 following 2 doses given 3 weeks apart. The duration of protection against COVID-19 is currently unknown. WHAT ARE THE RISKS OF THE PFIZER-BIONTECH COVID-19 VACCINE? Side effects that have been reported with the Pfizer-BioNTech COVID-19 Vaccine include: • injection site pain • tiredness • headache • muscle pain • chills • joint pain • fever • injection site swelling • injection site redness • nausea • feeling unwell • swollen lymph nodes (lymphadenopathy) There is a remote chance that the Pfizer-BioNTech COVID-19 Vaccine could cause a severe allergic reaction. A severe allergic reaction would usually occur within a few minutes to one hour after getting a dose of the Pfizer-BioNTech COVID-19 Vaccine. For this reason, your vaccination provider may ask you to stay at the place where you received your vaccine for monitoring after vaccination. Signs of a severe allergic reaction can include: • Difficulty breathing • Swelling of your face and throat • A fast heartbeat • A bad rash all over your body • Dizziness and weakness These may not be all the possible side effects of the Pfizer-BioNTech COVID-19 Vaccine. Serious and unexpected side effects may occur. Pfizer-BioNTech COVID-19 Vaccine is still being studied in clinical trials. WHAT SHOULD I DO ABOUT SIDE EFFECTS? If you experience a severe allergic reaction, call 9-1-1, or go to the nearest hospital. 4 Revised: December 2020 Call the vaccination provider or your healthcare provider if you have any side effects that bother you or do not go away. Complete and submit reports to VAERS online at https://vaers.hhs.gov/reportevent.html. For further assistance with reporting to VAERS call 1-800-822-7967. Please include “Pfizer-BioNTech COVID-19 Vaccine EUA” in the first line of box #18 of the report form. In addition, you can report side effects to Pfizer Inc. at the contact information provided below. Website Fax number Telephone number www.pfizersafetyreporting.com 1-866-635-8337 1-800-438-1985 You may also be given an option to enroll in v-safe. V-safe is a new voluntary smartphone-based tool that uses text messaging and web surveys to check in with people who have been vaccinated to identify potential side effects after COVID-19 vaccination. V-safe asks questions that help CDC monitor the safety of COVID-19 vaccines. V-safe also provides second-dose reminders if needed and live telephone follow-up by CDC if participants report a significant health impact following COVID-19 vaccination. For more information on how to sign up, visit: www.cdc.gov/vsafe. WHAT IF I DECIDE NOT TO GET THE PFIZER-BIONTECH COVID-19 VACCINE? It is your choice to receive or not receive the Pfizer-BioNTech COVID-19 Vaccine. Should you decide not to receive it, it will not change your standard medical care. ARE OTHER CHOICES AVAILABLE FOR PREVENTING COVID-19 BESIDES PFIZER-BIONTECH COVID-19 VACCINE? Currently, there is no approved alternative vaccine available for prevention of COVID-19. Other vaccines to prevent COVID-19 may be available under Emergency Use Authorization. CAN I RECEIVE THE PFIZER-BIONTECH COVID-19 VACCINE WITH OTHER VACCINES? There is no information on the use of the Pfizer-BioNTech COVID-19 Vaccine with other vaccines. WHAT IF I AM PREGNANT OR BREASTFEEDING? If you are pregnant or breastfeeding, discuss your options with your healthcare provider. WILL THE PFIZER-BIONTECH COVID-19 VACCINE GIVE ME COVID-19? No. The Pfizer-BioNTech COVID-19 Vaccine does not contain SARS-CoV-2 and cannot give you COVID-19. 5 Revised: December 2020 KEEP YOUR VACCINATION CARD When you get your first dose, you will get a vaccination card to show you when to return for your second dose of Pfizer-BioNTech COVID-19 Vaccine. Remember to bring your card when you return. ADDITIONAL INFORMATION If you have questions, visit the website or call the telephone number provided below. To access the most recent Fact Sheets, please scan the QR code provided below. Global website Telephone number www.cvdvaccine.com 1-877-829-2619 (1-877-VAX-CO19) HOW CAN I LEARN MORE? • Ask the vaccination provider. • Visit CDC at https://www.cdc.gov/coronavirus/2019-ncov/index.html. • Visit FDA at https://www.fda.gov/emergency-preparedness-and-response/mcmlegal-regulatory-and-policy-framework/emergency-use-authorization. • Contact your local or state public health department. WHERE WILL MY VACCINATION INFORMATION BE RECORDED? The vaccination provider may include your vaccination information in your state/local jurisdiction’s Immunization Information System (IIS) or other designated system. This will ensure that you receive the same vaccine when you return for the second dose. For more information about IISs visit: https://www.cdc.gov/vaccines/programs/iis/about.html. WHAT IS THE COUNTERMEASURES INJURY COMPENSATION PROGRAM? The Countermeasures Injury Compensation Program (CICP) is a federal program that may help pay for costs of medical care and other specific expenses of certain people who have been seriously injured by certain medicines or vaccines, including this vaccine. Generally, a claim must be submitted to the CICP within one (1) year from the date of receiving the vaccine. To learn more about this program, visit www.hrsa.gov/cicp/ or call 1-855-266-2427. WHAT IS AN EMERGENCY USE AUTHORIZATION (EUA)? The United States FDA has made the Pfizer-BioNTech COVID-19 Vaccine available under an emergency access mechanism called an EUA. The EUA is supported by a Secretary of Health and Human Services (HHS) declaration that circumstances exist to 6 Revised: December 2020 justify the emergency use of drugs and biological products during the COVID-19 pandemic. The Pfizer-BioNTech COVID-19 Vaccine has not undergone the same type of review as an FDA-approved or cleared product. FDA may issue an EUA when certain criteria are met, which includes that there are no adequate, approved, available alternatives. In addition, the FDA decision is based on the totality of scientific evidence available showing that the product may be effective to prevent COVID-19 during the COVID-19 pandemic and that the known and potential benefits of the product outweigh the known and potential risks of the product. All of these criteria must be met to allow for the product to be used in the treatment of patients during the COVID-19 pandemic. The EUA for the Pfizer-BioNTech COVID-19 Vaccine is in effect for the duration of the COVID-19 EUA declaration justifying emergency use of these products, unless terminated or revoked (after which the products may no longer be used). Manufactured by Pfizer Inc., New York, NY 10017 Manufactured for BioNTech Manufacturing GmbH An der Goldgrube 12 55131 Mainz, Germany LAB-1451-1.1 Revised: December 2020 Microbiol Infect Dis, 2021 Volume 5 | Issue 1 | 1 of 3 COVID-19 RNA Based Vaccines and the Risk of Prion Disease Classen Immunotherapies, Inc., 3637 Rockdale Road, Manchester, MD 21102, E-mail: classen@vaccines.net. J. Bart Classen, MD* Citation: Classen JB. COVID-19 RNA Based Vaccines and the Risk of Prion Disease. Microbiol Infect Dis. 2021; 5(1): 1-3. Research Article ABSTRACT Development of new vaccine technology has been plagued with problems in the past. The current RNA based SARSCoV-2 vaccines were approved in the US using an emergency order without extensive long term safety testing. In this paper the Pfizer COVID-19 vaccine was evaluated for the potential to induce prion-based disease in vaccine recipients. The RNA sequence of the vaccine as well as the spike protein target interaction were analyzed for the potential to convert intracellular RNA binding proteins TAR DNA binding protein (TDP-43) and Fused in Sarcoma (FUS) into their pathologic prion conformations. The results indicate that the vaccine RNA has specific sequences that may induce TDP-43 and FUS to fold into their pathologic prion confirmations. In the current analysis a total of sixteen UG tandem repeats (ΨGΨG) were identified and additional UG (ΨG) rich sequences were identified. Two GGΨA sequences were found. Potential G Quadruplex sequences are possibly present but a more sophisticated computer program is needed to verify these. Furthermore, the spike protein, created by the translation of the vaccine RNA, binds angiotensin converting enzyme 2 (ACE2), a zinc containing enzyme. This interaction has the potential to increase intracellular zinc. Zinc ions have been shown to cause the transformation of TDP-43 to its pathologic prion configuration. The folding of TDP-43 and FUS into their pathologic prion confirmations is known to cause ALS, front temporal lobar degeneration, Alzheimer’s disease and other neurological degenerative diseases. The enclosed finding as well as additional potential risks leads the author to believe that regulatory approval of the RNA based vaccines for SARS-CoV-2 was premature and that the vaccine may cause much more harm than benefit. * Correspondence: J. Bart Classen, MD, Classen Immunotherapies, Inc., 3637 Rockdale Road, Manchester, MD 21102, Tel: 410-377-8526. Received: 27 December 2020; Accepted: 18 January 2021 Microbiology & Infectious Diseases ISSN 2639-9458 Keywords COVID-19, Vaccines, Diabetes, Immunity. Introduction Vaccines have been found to cause a host of chronic, late developing adverse events. Some adverse events like type 1 diabetes may not occur until 3-4 years after a vaccine is administered [1]. In the example of type 1 diabetes the frequency of cases of adverse events may surpass the frequency of cases of severe infectious disease the vaccine was designed to prevent. Given that type 1 diabetes is only one of many immune mediated diseases potentially caused by vaccines, chronic late occurring adverse events are a serious public health issue. The advent of new vaccine technology creates new potential mechanisms of vaccine adverse events. For example, the first killed polio vaccine actually caused polio in recipients because the up scaled manufacturing process did not effectively kill the polio virus before it was injected into patients. RNA based vaccines offers special risks of inducing specific adverse events. One such potential adverse event is prion based diseases caused by activation of intrinsic proteins to form prions. A wealth of knowledge has been published on a class of RNA binding proteins shown to participating in causing a number of neurological diseases including Alzheimer’s disease and ALS. TDP-43 and FUS are among the best studied of these proteins [2]. The Pfizer RNA based COVID-19 vaccine was approved by the US FDA under an emergency use authorization without long term safety data. Because of concerns about the safety of this vaccine a study was performed to determine if the vaccine could potentially induce prion based disease. Methods Pfizer’s RNA based vaccine against COVID-19 was evaluated for the potential to convert TDP-43 and or FUS to their prion based Microbiol Infect Dis, 2021 Volume 5 | Issue 1 | 2 of 3 disease causing states. The vaccine RNA was analyzed for the presence of sequences that can activate TDP-43 and FUS. The interaction of the transcribed spike protein with its target was analyzed to determine if this action could also activate TDP-43 and FUS. Results Analysis of the Pfizer vaccine against COVID-19 identified two potential risk factors for inducing prion disease is humans. The RNA sequence in the vaccine [3] contains sequences believed to induce TDP-43 and FUS to aggregate in their prion based conformation leading to the development of common neurodegerative diseases. In particular it has been shown that RNA sequences GGUA [4], UG rich sequences [5], UG tandem repeats [6], and G Quadruplex sequences [7], have increased affinity to bind TDP-43 and or FUS and may cause TDP-43 or FUS to take their pathologic configurations in the cytoplasm. In the current analysis a total of sixteen UG tandem repeats (ΨGΨG) were identified and additional UG (ΨG) rich sequences were identified. Two GGΨA sequences were found. G Quadruplex sequences are possibly present but sophisticated computer programs are needed to verify these. The spike protein encoded by the vaccine binds angiotensin converting enzyme 2 (ACE2), an enzyme which contains zinc molecules [8]. The binding of spike protein to ACE2 has the potential to release the zinc molecule, an ion that causes TDP-43 to assume its pathologic prion transformation [9]. Discussion There is an old saying in medicine that “the cure may be worse than the disease.” The phrase can be applied to vaccines. In the current paper the concern is raised that the RNA based COVID vaccines have the potential to cause more disease than the epidemic of COVID-19. This paper focuses on a novel potential adverse event mechanism causing prion disease which could be even more common and debilitating than the viral infection the vaccine is designed to prevent. While this paper focuses on one potential adverse event there are multiple other potential fatal adverse events as discussed below. Over the last two decades there has been a concern among certain scientists that prions could be used as bioweapons. More recently there has been a concern that ubiquitous intracellular molecules could be activated to cause prion disease including Alzheimer’s disease, ALS and other neurodegenerative diseases. This concern originates due to potential for misuse of research data on the mechanisms by which certain RNA binding proteins like TDP-43, FUS and others can be activated to form disease causing prions. The fact that this research, which could be used for bioweapons development, is funded by private organizations including the Bill and Melinda Gates Foundation, and Ellison Medical Foundation [2] without national/international oversight is also a concern. In the past, for example, there were prohibitions for publishing information pertaining to construction of nuclear bombs. Published data has shown that there are several different factors that can contribute to the conversion of certain RNA binding proteins including TDP-43, FUS and related molecules to their pathologic states. These RNA binding proteins have many functions and are found in both the nucleus and the cytoplasm. These binding proteins have amino acid regions, binding motifs that bind specific RNA sequences. Binding to certain RNA sequences when the proteins are in the cytoplasm is believed to causes the molecules to fold in certain ways leading to pathologic aggregation and prion formation in the cytoplasm [2]. The current analysis indicates Pfizer's RNA based COVID-19 vaccine contains many of these RNA sequences that have been shown to have high affinity for TDP-43 or FUS and have the potential to induce chronic degenerative neurological diseases. Zinc binding to the RNA recognition motif of TDP-43 is another mechanism leading to formation of amyloid like aggregations [9]. The viral spike protein, coded by the vaccine RNA sequence, binds ACE2 an enzyme containing zinc molecules [8]. This interaction has the potential to increase intracellular zinc levels leading to prion disease. The initial binding could be between spike proteins on the surface of the cell transfected by the vaccine and ACE2 on the surface of an adjacent cell. The resulting complex may become internalized. Alternatively, the interaction could initially take place in the cytoplasm of a cell that makes ACE2 and has been transfected with the vaccine RNA coding for the spike protein. The interaction is quite concerning given the belief that the virus causing COVID-19, SARS-CoV-2, is a bioweapon [10,11] and it is possible that the viral spike protein may have been designed to cause prion disease. Another related concern is that the Pfizer vaccine uses a unique RNA nucleoside 1-methyl-3'-pseudouridylyl (Ψ). According to FDA briefing documents, this nucleoside was chosen to reduce activation of the innate immune system [12]. RNA molecules containing this nucleoside will undoubtedly have altered binding [13]. Unfortunately, the effect on TDP-43, FUS and other RNA binding proteins is not published. The use of this nucleoside in a vaccine can potentially enhance the binding affinity of RNA sequences capable of causing TDP-43 and FUS to assume toxic configurations. There are many other potential adverse events that can be induced by the novel RNA based vaccines against COVID-19. The vaccine places a novel molecule, spike protein, in/on the surface of host cells. This spike protein is a potential receptor for another possibly novel infectious agent. If those who argue that the COVID-19 is actually a bioweapon are correct, then a second potentially more dangerous virus may be released that binds spike protein found on the host cells of vaccine recipients. Data is not publicly available to provide information on how long the vaccine RNA is translated in the vaccine recipient and how long after translation the spike protein will be present in the recipient’s cells. Such studies pertaining to in vivo expression will be complex and challenging. Genetic diversity protects species from mass casualties caused by infectious agents. One individual may be killed by a virus while Microbiol Infect Dis, 2021 Volume 5 | Issue 1 | 3 of 3 another may have no ill effects from the same virus. By placing the identical receptor, the spike protein, on cells of everyone in a population, the genetic diversity for at least one potential receptor disappears. Everyone in the population now becomes potentially susceptible to binding with the same infectious agent. Autoimmunity and the opposing condition, metabolic syndrome, are well know adverse events caused by vaccines [14]. COVID-19 infections are associated with the induction of autoantibodies and autoimmune disease [15,16] making it more than plausible a vaccine could do the same. One author has found amino acid sequences coded by the spike protein to be identical to sequences in human proteins including proteins found in the CNS [17]. Autoimmunity can also be induced by epitope spreading when a foreign antigen, like the spike protein, is presented by an antigen presenting cell that also has self molecules attached to its MHC molecules. Finally, others working in the field have published additional support that COVID-19 vaccines could potentially induce prion disease. Authors [18] found prion related sequences in the COVID-19 spike protein which were not found in related coronaviruses. Others [19] have reported a case of prion disease, Creutzfeldt-Jakob disease, initially occurring in a man with COVID-19. Many have raised the warning that the current epidemic of COVID-19 is actually the result of an bioweapons attack released in part by individuals in the United States government [10,11]. Such a theory is not far fetched given that the 2001 anthrax attack in the US originated at Fort Detrick, a US army bioweapon facility. Because the FBI’s anthrax investigation was closed against the advice of the lead FBI agent in the case, there are likely conspirators still working in the US government. In such a scenario the primary focus of stopping a bioweapons attack must be to apprehend the conspirators or the attacks will never cease. Approving a vaccine, utilizing novel RNA technology without extensive testing is extremely dangerous. The vaccine could be a bioweapon and even more dangerous than the original infection. References 1. Classen JB, Classen DC. Clustering of cases of insulin dependent diabetes (IDDM) occurring three years after Hemophilus influenza B (HiB) immunization support causal relationship between immunization and IDDM. Autoimmunity. 2002; 35: 247-253. 2. King OD, Gitler AD, Shorter J. The tip of the iceberg: RNAbinding proteins with prion-like domains in neurodegenerative disease. Brain Res. 2012; 1462: 61-80. 3. WHO, International Non Proprietary Names Program: 11889. 9/2020. 4. Kapeli K, Pratt GA, Vu AQ, et al. Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15

The_Dangers_of_the_covid_19_Vaccine_Report_-_Updated_07.26.2021.pdf (shopify.com)

The next step, and most important work is still to be done and if someone out there can offer an assist in uncovering another piece of this puzzle, I have a job for you, a way to contribute, and together I believe we absolutely can save the world! Email us @ axiomhq@conspiracyaxiomalliance.com Join the Alliance.estateartistry.com. HOW TO ESCAPE DEATH AND INJURY IF YOU HAVE RECEIVED ANY OF THE COVID VACCINES. People we love took "the shot heard around the world" I do not want them to die, I believe we can find the cure for the "cure" and we can start NOW! Be a voice help us save the world.. Jack.

Cyberwarfare

100 episodes